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Abstract
Background: To explore the hypothesis that maternal periodontitis is associated with increased risk for Intrauterine
Growth Restriction (IUGR), we examined the risk of IUGR in relation to periodontal treatment before, during and
after pregnancy.
Methods: We conducted a retrospective cohort analysis of insurance claims data from 2009 to 2012 for women
who delivered a singleton live birth (n = 32,168). IUGR was examined as a function of type and timing of dental
treatment, adjusting for potential confounders in logistic regression. Sensitivity analysis evaluated the potential
effects of unmeasured confounding.
Results: Women who received periodontal treatment after delivery, indicating the presence of untreated periodontal
disease during pregnancy, had significantly higher odds of IUGR compared to women who received no periodontal
treatment (adjusted OR 1.5, 95% CI 1.2, 1.8).
Conclusions: Periodontal treatment provided in the immediate postpartum period, a proxy for periodontitis during
gestation, was associated with increased risk of IUGR.
Keywords: Periodontal treatment, Fetal inflammatory response, Intrauterine growth restriction
Background
In industrialized countries, about four-fifths of low birth-
weight infants are born preterm and a fifth of these pre-
term births are due to intrauterine growth restriction
(IUGR) [1]. In the absence of congenital malformations
and/or chromosomal anomalies, IUGR entails two dis-
tinct processes: constitutional smallness, or pathological
growth restriction [2]. The prevalence of IUGR varies
substantially across populations, but prevalence rates
range between 3 and 7%. The etiology of IUGR remains
undetermined, but several risk factors for the condition
have been identified. These include advanced maternal
age, increased parity, smoking during pregnancy, low
pre-pregnancy body mass index and low gestational
weight gain (due to low energy intake), short maternal
stature, poor maternal nutrition, maternal race/ethnicity,
and low socioeconomic status being some of the
important risk factors [3]. Maternal, placental and fetal
infections are strongly implicated in the development of
IUGR.
Periodontal diseases are associated with transient
bacteremia that may facilitate dissemination of oral bac-
teria to the uterus, with subsequent infiltration of the
amniotic fluid and the umbilical cord and invasion of
the placenta. It is believed that hematogenous transport
of bacteria and/or pro-inflammatory mediators from
sites of periodontal infection into the placenta, fetal
membranes, and amniotic cavity induces pathological
processes that lead to adverse perinatal outcomes, in-
cluding IUGR [4–7]. Uteroplacental infection and in-
flammation are thought to play key roles in the etiology
of IUGR [8], with fetal inflammatory response syndrome
being characterized as the important cause of IUGR [9].
Collectively, these infections account for up to 15% of
IUGR cases [10].
Periodontal infections are associated with an increased
risk for adverse pregnancy outcomes, including preterm
delivery, and preeclampsia, but whether this increased
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risk also applies to IUGR has not been established. Since
infections play an important role in IUGR, we hypothe-
sized that: (i) maternal periodontitis is associated with
an increased risk for IUGR; and (ii) treatment for peri-
odontitis in the immediate postpartum period signifies
presence of untreated periodontitis during pregnancy,
and is associated with elevated risk of IUGR. Further-
more, given the increased risk of recurrence of IUGR
and the temporal persistence of periodontal infections,
we hypothesized that parity will be an effect modifier of
the association between periodontal infection and risk of
IUGR.
We tested these hypotheses by examining medical and
dental insurance records in a large cohort of 32,168
women, comparing rates of IUGR among women under-
going periodontal care, other types of dental treatment,
and those receiving no dental treatment, before, during
and after pregnancy.
Methods
Study design and data sources
This retrospective cohort study examined insurance re-
cords of women concurrently enrolled in medical and
dental insurance plans through Aetna Inc., a nationwide,
private health insurer. Aetna’s data warehouse holds
claim information on members for a four-year period.
We therefore restricted the analysis to women that deliv-
ered a singleton live-birth between January 2010 and De-
cember 2011, and then included claims data for those
birth events up to one year before gestation and up to
one year after the birth event. We chose to restrict the
study to singleton gestations, since the etiology and risk
factors for IUGR vary between singleton and multiple
births. The study cohort was restricted to women who
had both medical and dental insurance, who were be-
tween 13 and 50 years of age at the time of delivery, and
for whom zip code level data and other covariates were
available. The analytic sample included 32,168 women.
Using data from 212,427 dental claim records for the
period January 2009 through December 2012, proce-
dures performed before, during and after pregnancy
were identified and classified using the Code on Dental
Procedures and Nomenclature Current Dental Termin-
ology (CDT) 2009–10 edition for procedures occurring
before 2011, and the CDT 2011/2012 edition for proce-
dures from 2011 onwards. Maternal oral treatment type
included periodontal treatment, prophylaxis, other den-
tal treatment, or no oral treatment of any kind during
the study period. Periodontal treatment was provided by
general dentists and periodontists. Oral prophylaxis pro-
cedures can be provided by dentists or dental hygienists,
however in the United States most oral prophylaxis
procedures are provided by dental hygienists. Periodon-
tal treatment included surgical and non-surgical codes
(Additional file 1: Table S1). Because the insurance data-
base did not include indicators of conception, the date
of conception was estimated from the date of birth. For
analytic purposes, each dental treatment category was
considered in relation to the time period in which it oc-
curred: pre-conception, during gestation, or after birth.
The insurance dataset contained diagnosis codes and
treatment codes for medical care, however it was limited
to treatment codes for dental services. In the United
States, dentists are only required to provide treatment
codes for reimbursement via a dental claim. Given that
periodontal disease is a chronic condition, periodontal
treatment occurring after delivery was considered to in-
dicate that periodontitis was present and untreated dur-
ing pregnancy.
Using data extracted from 2,622,764 medical claims re-
cords, for the period January 2009 through December
2012, presence of IUGR was assumed if one or more
International Classification of Diseases (ICD) 9th revision
codes indicating slow fetal growth and fetal malnutrition
(764.x), or poor fetal growth affecting management of
mother (656.5x) had been used. Fetal growth restriction
was defined as an IUGR diagnosis within 14 days of deliv-
ery; thus, in this study, the term IUGR refers to growth re-
striction defined accordingly. In each record, both primary
and secondary claims were searched. Multiple births were
identified and eliminated from the analytic file using sup-
plementary delivery codes V27.2 to V27.9.
Maternal income, race and ethnicity were not available
in the insurance database. We therefore imputed these
characteristics based on the zip code of residence for
each woman at the time of insurance enrollment, and
the 2010 United States Census zip code level data for
these variables. We identified complications of preg-
nancy using ICD-9 codes (Additional file 1: Table S2).
Because not all women had dental coverage for the en-
tire study period, months of enrollment for each woman
was included as a covariate. The sample included
women from all 50 states, the District of Columbia, and
Puerto Rico.
Statistical analysis
The risk of IUGR was associated with types of dental
and periodontal treatment, as previously defined. We fit
logistic regression models from which we derived odds
ratios (OR) and 95% confidence intervals (CI) to assess
the magnitude of the effect. In these models, we adjusted
for potential confounding factors including pregnancy
complications, maternal age at delivery, primiparity, zip
code level income, race, and ethnicity; the models were
also adjusted for duration of continuous dental coverage
during the study period. Annual income was analyzed in
quintiles, and categorized in US dollars as ≤28,125;
28,126 to 33,500; 33,501 to 39,283, 39,284 to 48,831;
Ananth et al. BMC Oral Health  (2018) 18:161 Page 2 of 8
and ≥ 48,832. To assess non-linear effects of maternal
age on the odds of incident IUGR, we included a quad-
ratic term for age in the regression models.
To test for parity-related effect modification, a two-
way interaction term between periodontal treatment and
primiparity was included in the logistic regression
model. Since the Wald-type chi-square test for the inter-
action term was significant (P < 0.01), we present the re-
sults of models stratified by parity.
To determine whether risk of IUGR increases with se-
verity of periodontitis, we examined the rate of IUGR in
relation to the number and type of periodontal treatment
procedures, and compared women who received surgical
as opposed to non-surgical periodontal treatment.
Sensitivity analysis
Since the association between periodontal treatment and
IUGR is likely affected by unmeasured confounding, we
undertook a sensitivity analysis to evaluate the extent to
which unmeasured confounding may have impacted the
associations [11]. This sensitivity analysis was based on
the following assumptions: (i) the prevalence rates of the
unmeasured confounder among pregnancies with and
without IUGR were 3% and 6%, respectively; and (ii) the
odds ratio of IUGR comparing the presence versus ab-
sence of unmeasured confounding was allowed to vary
between 0.1 (protective) to 1.0 in 0.1 increments, and
2.0 (increased risk) to 10 in 1.0 increments. The evalu-
ation of the impact of unmeasured confounding was
based on fairly conservative assumptions.
Results
Of the 32,168 women in the study, 18,593 (57.8%) re-
ceived some form of dental treatment during the study
period; 9.0% (n = 2895) received periodontal treatment,
41.2% (n = 13,246) received prophylaxis and 7.6% (n =
2452) received some other form of dental treatment
(Table 1). The mean maternal age at the time of delivery
was 30.8 (standard deviation (SD) = 5.6); subjects lived in
zip codes with median Black population of 5% (range 0–
99), and median Hispanic population of 8% (range 0–
100). Complications of pregnancy were documented for
33.9% of the women in the study. On average, women
were enrolled in a dental plan for 27.9 months (SD =
13.3) during the study period. There were relatively
small differences between dental treatment groups with
respect to each of the above covariates.
Table 2 shows the frequency of each type of periodontal
treatment in the cohort. The most frequent non-surgical
periodontal procedure was scaling and root planing, which
was documented for 7.4% (n = 2388) of the women. Full
mouth debridement (n = 584, 1.8%) and localized delivery
of chemotherapeutic agents (n = 229, 0.7%) were less fre-
quent. Surgical periodontal procedures occurred only
rarely. For over two thirds of the 2895 women who re-
ceived periodontal treatment during the study period, that
treatment occurred only in the period after birth (n =
1956, 67.6%). A total of 440 (15.2%) received dental treat-
ment only during gestation, and 343 (11.8%) received
treatment in the period prior to conception. 753 (2.6%) re-
ceived treatment in the gestation and post-gestation pe-
riods, 550 (1.9%) received treatment in the pre-gestation
and post-gestation periods, and 232 (0.8%) received treat-
ment in the pre-gestation and gestation periods.
IUGR was documented in 2027 fetuses (6.3%). The as-
sociation between dental treatment before, during and
after gestation and the risk of IUGR is shown in Table 3.
The incidence of IUGR was 9.2% (n = 192) among those
receiving periodontal treatment after delivery and 6.1%
(n = 1835) for those receiving no periodontal treatment.
The odds of IUGR for those receiving periodontal treat-
ment post-gestation compared to those receiving no
periodontal treatment was 1.5 (95% CI 1.2, 1.8) following
adjustment for confounders. The odds of IUGR was ele-
vated among multiparous women who received peri-
odontal treatment post-gestation (OR 1.6, 95% CI 1.3,
1.9). Among primiparous women who received peri-
odontal treatment post-gestation, the risk of IUGR was
not elevated (OR 1.3, 95% CI 1.0, 1.8).
The rate of IUGR among those with no dental treat-
ment at any time before, during or after pregnancy was
6.0%, which was marginally but significantly lower than
the IUGR rate of those who received any treatment
(6.5%; p = 0.048); there was also a marginally significant
difference in IUGR rates in the post-gestational period
between those who received no dental treatment in this
period (6.1%) and those who received some form of den-
tal treatment in this period (6.6%; p = .049). The slightly
elevated IUGR rates of those receiving any form of den-
tal treatment is clearly driven by the increased IUGR
rates associated with periodontal treatment, as shown in
Table 3.
Sensitivity analysis for unmeasured confounding
The odds ratios corrected for unmeasured confounder(s)
are shown in Fig. 1. For instance, if the odds ratio of
IUGR comparing the presence versus absence of an un-
measured confounder was 2.0, the bias-corrected odds
ratio for each of the three scenarios were 0.7 (95% CI
0.5, 1.1) for pre-gestation periodontal treatment, 1.2
(95% CI 0.9, 1.8) for periodontal treatment during preg-
nancy, and 1.5 (95% CI 1.3, 1.8) for periodontal treat-
ment post-gestation. For odds ratios of the unmeasured
confounder over 5, the bias-corrected odds ratio were
enhanced for both periodontal treatment during preg-
nancy and post-gestation. These findings confirm the
confounder-adjusted odds ratios reported earlier
(Table 3), and when unmeasured confounding is taken
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into account, the associations between periodontal treat-
ment both during pregnancy and post-gestation are as-
sociated with increased odds of IUGR.
To determine whether severity of post-gestation peri-
odontal care was associated with the likelihood of IUGR,
we developed a four-category measure capturing the
number of claims for post-gestational maternal peri-
odontal care: zero, one, two, and three or more. The rate
of IUGR increased from 6.1% for those with no peri-
odontal care to 8.1% among those with 1 instance of
periodontal treatment, 9.8% for those with 2 instances of
periodontal treatment, and peaking at 11.1% for those
with 3 or more instances of periodontal treatment after
birth (P < 0.01).
Discussion
The results indicate an association between maternal
periodontal disease and odds of IUGR. We observed sig-
nificantly elevated odds of IUGR among women who
experienced periodontal disease during pregnancy, as
Table 1 Distribution of maternal sociodemographic characteristics by dental treatment type (n = 32,168)
Maternal characteristics Total (%) No dental
treatment (%)
Periodontal treatment (%) Prophylaxis (%) Other dental
treatment (%)
P-value
Number of subjects (%) 32,168 (100.0) 13,575 (42.2) 2895 (9.0) 13,246 (41.2) 2452 (7.6)
Maternal age (years) < 0.01
< 20 2.6 3.4 1.6 1.9 2.7
20–24 10.8 12.5 13.9 7.6 15.3
25–29 26.0 26.9 31.8 23.1 29.9
30–34 34.3 32.7 28.5 37.7 31.5
≥ 35 26.3 24.4 24.2 29.6 20.6
Mean age (SD) 30.8 (5.6) 30.4 (5.8) 30.2 (5.5) 31.6 (5.3) 29.9 (5.7) < 0.01




1st (≤28,125) 6.3 6.7 9.0 5.2 6.6
2nd (28,126 to 33,500) 7.3 7.8 10.5 5.8 8.4
3rd (33,501 to 39,283) 10.5 11.0 10.7 9.5 13.4
4th (39,284 to 48,831) 20.6 20.3 22.7 19.9 23.4
5th (≥48,832) 55.3 54.2 47.2 59.6 48.1











Black race (%) < 0.01
≤ 10 70.0 66.3 71.7 73.8 67.9
11–35 20.5 21.8 19.7 19.0 22.8
36–50 2.8 3.1 2.9 2.4 3.6
≥ 51 6.6 8.8 5.6 4.7 5.8
Median (range) % 5 (0, 99) 6 (0, 99) 5 (0, 98) 5 (0, 99) 5 (0, 98) < 0.01
Hispanic ethnicity (%) < 0.01
≤ 5 40.4 39.1 31.8 44.4 36.8
6–10 19.8 18.9 22.8 20.1 19.5
11–20 18.3 18.6 18.9 17.9 18.5
21–42 13.0 13.3 16.1 11.6 15.0
≥ 43 8.4 10.1 10.3 6.0 10.2
Median (range) % 8 (0, 100) 8 (0, 100) 9 (0, 99) 7 (0, 100) 9 (0, 97) < 0.01
Complications of pregnancy
(%)a
33.9 34.0 34.6 33.1 36.5 < 0.01
Dental enrollment months,
Median (range)
28 (1, 46) 22 (1, 46) 33 (1, 46) 32 (1, 46) 29 (1, 46) < 0.01
aDetails of the pregnancy complications are shown in Additional file 1: Table S2
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evidenced by periodontal treatment shortly after giving
birth. We also found that delivery of a higher volume of
periodontal treatment, a possible indicator of more severe
periodontal disease, was associated with increased inci-
dence of IUGR. The effect was strongest among those
who received periodontal treatment after giving birth, an
indication of untreated periodontal disease during preg-
nancy. While relatively few women received periodontal
treatment during pregnancy, the sensitivity analysis sug-
gested that there may be elevated risk of IUGR during this
period as well. However, contrary to our initial hypothesis,
the risk of IUGR in relation to the timing of the receipt of
dental treatment did not vary by parity.
Limitations of the data
Diagnosis of IUGR was based on ICD coding, and this
may have introduced some misclassification. Women
carrying IUGR fetuses, particularly those that are diag-
nosed as not being severely growth restricted, are less
likely to undergo clinician-initiated obstetrical interven-
tion (labor induction or a prelabor cesarean) and less
likely to have a diagnosis of IUGR recorded [12]. How-
ever, for severe IUGR (e.g., estimated fetal weight below
the third or the first percentiles), misclassification of
IUGR status is very unlikely since growth restriction
serves as a sentinel cause for obstetrical intervention,
and is therefore billed for insurance reimbursement. For
the same reason, we believe the recording of the expos-
ure is accurate in this data system because periodontal
treatment is the basis for a reimbursable claim.
Second, despite adjustment for several confounders,
we lack data on smoking and maternal pre-pregnancy
body-mass index. However, the sensitivity analysis con-
ducted to determine the potential effect of unmeasured
confounding indicates that our models are robust. Fi-
nally, dental data is based on CDT codes that reflect
treatment of periodontal disease rather than diagnosis.
However, we believe that the treatment codes are suffi-
ciently specific to infer presence of periodontal disease.
While women included in this study are from virtually
all states in the US, the insured populations are from
middle to higher-income socioeconomic strata. This
should be considered while generalizing the results from
the study; however, it is unlikely that the association be-
tween IUGR and infections in general, and periodontal
disease in particular, would be any lower among poorer
women than among those we studied.
It may appear anomalous in terms of causal reasoning
that the relationship we report is between an outcome
(IUGR) that occurs prior to an exposure (periodontal
treatment in the period immediately after birth). However,
periodontal disease is a chronic condition. Therefore, it is
plausible to assume that women who were treated in the
immediate post-gestation period experienced periodontitis
and its systemic impact during gestation.
Table 2 Frequency (%) of periodontal surgical and non-surgical
procedures among women in sample (n = 32,168)a
Procedure category Number % of total sample
Surgical procedures
Gingival flap 11 < 0.1
Osseous surgery 40 0.1
Bone replacement graft 58 0.2
Tissue regeneration procedure 61 0.2
Non-surgical procedures
Scaling and root planing 2388 7.4
Full mouth debridement 584 1.8
Localized chemotherapeutic agents 229 0.7
aNumber of women who had at least one instance of each procedure; a
woman may have had more than one procedure but is counted once in each
procedure category







Adjusted odds ratio (95% confidence interval)
Overall Primiparous women Multiparous women
Periodontal Pre-gestation 428 22 (5.1%) 0.7 (0.4, 1.1) 0.5 (0.2, 1.1) 0.9 (0.5, 1.5)
Gestation 540 40 (7.4%) 1.2 (0.8, 1.7) 1.4 (0.8, 2.4) 1.1 (0.7, 1.7)
Post-birth 2088 192 (9.2%) 1.5 (1.2, 1.8) 1.3 (1.0, 1.8) 1.6 (1.3, 1.9)
Prophylaxis Pre-gestation 3387 220 (6.5%) 1.0 (0.8, 1.3) 1.0 (0.7, 1.6) 1.0 (0.7, 1.4)
Gestation 7043 409 (5.8%) 1.0 (0.8, 1.2) 1.1 (0.8, 1.6) 0.9 (0.7, 1.2)
Post-birth 11,743 743 (6.3%) 1.0 (0.8, 1.2) 0.9 (0.7, 1.2) 1.0 (0.9, 1.3)
Any dental Pre-gestation 4655 306 (6.6%) 1.2 (0.9, 1.5) 1.0 (0.7, 1.5) 1.2 (0.9, 1.7)
Gestation 8986 535 (6.0%) 0.9 (0.7, 1.1) 0.8 (0.6, 1.2) 0.9 (0.7, 1.2)
Post-birth 14,969 986 (6.6%) 1.1 (0.9, 1.3) 1.2 (0.9, 1.6) 1.1 (0.9, 1.3)
Odds ratios were adjusted for the confounding effects of maternal age, maternal age-square, household income, proportions of African-American and Hispanic
ethnicities, and complications of pregnancy. An individual subject may have had a claim in more than one time period, and/or may have received more than one
type of treatment in a given time period; the regression models adjust for these instances of multiple treatment exposures
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Finally, while we report that there is an increase in the
rate of IUGR as a function of increasing number of
treatments for periodontal disease, there are many fac-
tors that determine frequency of treatment; therefore,
this finding is only suggestive of a relationship between
the severity of periodontal disease and increased risk of
IUGR.
Strengths of the study
In this study, a large sample of integrated medical
and dental claims data provided a unique opportunity
to explore the association between IUGR and peri-
odontitis. In addition, the findings appear robust fol-
lowing adjustment for observed confounders, in fact
correction for unmeasured confounding makes the
associations stronger. Conducting secondary analyses
using insurance data to shed light on the possible causes
of negative birth outcomes is highly economical, and valu-
able in suggesting directions for future research.
Biological interpretations
The finding that periodontal treatment post-gestation
was associated with an increased risk of IUGR in a large
national sample add to the growing body of literature in-
dicating a relationship between periodontal infection
and related inflammation with adverse birth outcomes
[4–8, 13]. Periodontal treatment in the period immedi-
ately following gestation is interpreted as signifying that
periodontal disease was present during gestation. The
inflammatory process associated with periodontal dis-
ease and the presence of periodontal pathogens in the
blood can affect the fetus and the placenta [4].
This study utilized periodontal treatment as a proxy
for the presence of periodontal disease. Periodontal
treatment during gestation was expectedly rare and was
also low during the pre-gestational period; our sample
size was therefore too small to evaluate effects of treat-
ment during pre-gestation and gestation. We expect that
treatment during the pre-gestational and gestational pe-
riods to have limited adverse impact on birth outcomes.
Tonetti and colleagues observed a short term increase in
the systemic inflammatory response immediately follow-
ing periodontal treatment which was then followed by a
decrease in inflammation [14]. The finding that deleteri-
ous effects associated with periodontal therapy are
short-lived is consistent with our finding of no statisti-
cally significant effect of treatment in the period prior to
gestation and during gestation. However, periodontal
treatment provided immediately following birth, which
we found to be significantly related to IUGR appears to
be a marker of disease during gestation.
Boggess and colleagues also observed that the inci-
dence of small for gestational age increased with peri-
odontal disease severity [15]. These findings are
consistent with observations by several other investiga-
tors. In a study of Brazilian women, Siqueria and col-
leagues found increased odds of IUGR (adjusted OR
2.06, 95% CI 1.07, 4.19) among women diagnosed with
periodontitis [16]. Similarly, Kumar and colleagues re-
ported an increased association between periodontitis
and IUGR, which was attenuated after adjusting for con-
founders [17]. The associations that we report are very
similar to those of the Brazilian study.
The insured and employed population in our analyses
is in the upper quartile of income in the United States
and would be expected to have better oral hygiene and
prevention practices. In addition, it is expected that util-
izing treatment as a proxy for periodontal disease to
some extent underestimates the true incidence of
Fig. 1 Sensitivity Analysis for Unmeasured Confounding Between
Periodontal Treatment Before, During and Post-Gestation and IUGR.
Sensitivity analysis to evaluate the impact of unmeasured confounding
of the association between periodontal treatment before (top panel),
during (middle panel), and post-gestation (bottom panel) and IUGR.
The observed confounder-adjusted odds ratio and 95% confidence
interval are also shown for each panel. The unmeasured confounding
bias-corrected odds ratio of IUGR for each of the three periodontal
treatment periods are shown for prevalence estimates varying from 0.5
to 6.0% of the unmeasured confounder among both the IUGR and
non-IUGR groups. The odds ratio of IUGR in relation to the unmeasured
confounder is assumed to be 1.25. The red circle for each panel shows
the bias-corrected odds ratio for one scenario of the prevalence of the
unmeasured confounder of 2% and 4% among IUGR and non-IUGR
groups, respectively, and the odds ratio of IUGR in relation to the
unmeasured confounder of 1.25. The bias-corrected odds ratio for each
of the three scenarios are 0.9 (95% CI 0.6, 1.5) for pre-gestation
periodontal treatment, 1.6 (95% CI 1.1, 2.3) for periodontal
treatment during pregnancy, and 2.0 (95% CI 1.6, 2.3) for
periodontal treatment post-gestation
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periodontal disease. In our analytical sample, maternal
periodontal disease, indirectly assessed through the
delivery of periodontal treatment in the immediate post-
partum period, affected 9% of the women. By compari-
son, earlier studies have reported prevalence rates of
56–61% for maternal periodontitis [18, 19]. It should be
noted that while we and Siquiera and colleagues [16]
observed an increased odds for growth restriction with
periodontal disease, other studies did not find such a
relationship [20].
Conclusions
Periodontal disease manifests itself as destruction of the
supporting structures of the teeth and is associated with
systemic dissemination of bacteria and bacterial prod-
ucts as well as the release of inflammatory mediators
that can adversely impact the placenta resulting in fetal
growth restriction. In our analysis, IUGR was present in
6.3% of the sample. In 2012, 46% of the United States
adult population was estimated to have experienced
periodontal disease [21]. The high prevalence of peri-
odontal disease in adults, and the cost associated with
the morbidity and mortality of adverse birth outcomes,
justifies further investigation of the systemic impact of
periodontal infection/inflammation on the feto-placental
unit.
As demonstrated in this study, research that involves
the integration of medical and dental records can be in-
formative in elucidating the role of potential exposures
on adverse outcomes, and may ultimately lead to im-
proved patient outcomes and more cost-effective care
[22]. In particular, the use of combined medical and den-
tal national insurance claims data provides an opportun-
ity to explore the association of birth outcomes with
dental health and dental treatment in women of child-
bearing age. 56% of American adults aged 19–64 had
private dental insurance in 2009, and 10% of all proced-
ure types in the dental office were related to periodon-
tics [23, 24]. Data were obtained from a national
insurance carrier that provides medical insurance to 23.5
million persons, and dental coverage to about 14.6 mil-
lion persons across the United States [25].
In this retrospective study we show an association be-
tween periodontal treatment as a proxy for the presence
of periodontal disease and IUGR, however randomized
controlled trials are needed to establish the efficacy of
periodontal therapy on pregnancy outcomes such as fetal
growth restriction. Periodontal care should be empha-
sized for women of childbearing age to improve general
oral health. Policies encouraging evaluation and early
intervention to control/eliminate periodontal pathology
prior to pregnancy may be able to reduce the risk of
IUGR and related complications in the newborn.
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